Give your ponytail a voluminous upgrade with this easy hack. Perfect for adding lift and style to long hair, this tutorial ensures your ponytail looks fuller and lasts all day.

Sax said the twice-a-year shot might appeal to those who aren't willing or able to take a daily pill. "The key is getting people to take (PrEP) and having them reliably do so," Sax said.

Steven John After the twice-baked potatoes cool for a few minutes, they're ready to enjoy. I like serving them alongside steak, roasted chicken, fish, pan-seared tofu, or seitan.

Princess Beatrice, daughter of Prince Andrew and Sarah Ferguson, looked magnificent with her swishy waist-length ponytail in a colour-clashing outfit for the third day of Royal Ascot 2025.

How to do a slick ponytail As seen on the Spring Summer 2025 runways and this year’s awards season red carpets, including the likes of Hoyeon Jung, the slicked-back ponytail is making a major ...

Korean actors Shin Min-a and Ju Ji-hoon lead the cast of the live-action series adaptation of Korean web novel and webtoon series "The Remarried Empress." ...

A 66-year-old man has been killed by a Chautauqua County Sheriff’s deputy after an exchange of gunfire after officers responded to a domestic incident on Wednesday in the town of Mina. According to ...

FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections By Joseph Walker and ...

Billy Joel reveals he attempted suicide twice in his new documentary, 'Billy Joel: And So It Goes,' which premiered at Tribeca Festival in New York City.

The drug is lenacapavir. The twice-yearly formulation has the brand name Yeztugo. Phase 3 trials showed that 99.9% of those using the injections remained HIV-negative at a two-year follow-up.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.